immunotherapy Archives - Page 3 of 3

Antengene Announces Phase I Study of Anti-CD24 Monoclonal Antibody ATG-031

September 21, 2023September 21, 2023

Antengene Corporation Limited (“Antengene” SEHK: 6996.HK), a leading commercial-stage innovative, global biopharmaceutical company dedicated to discovering, developing, and commercializing first-in-class…

Ariceum Therapeutics doses first patient with its first-in-class targeted radiopharmaceutical drug satoreotide in its Phase Ib study in small cell lung cancer

September 7, 2023September 7, 2023

Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain hard-to-treat cancers, is…